GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Psomagen Inc (XKRX:950200) » Definitions » Beneish M-Score

Psomagen (XKRX:950200) Beneish M-Score : -3.70 (As of Jun. 04, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Psomagen Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.7 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Psomagen's Beneish M-Score or its related term are showing as below:

XKRX:950200' s Beneish M-Score Range Over the Past 10 Years
Min: -3.7   Med: -2.71   Max: -1.92
Current: -3.7

During the past 6 years, the highest Beneish M-Score of Psomagen was -1.92. The lowest was -3.70. And the median was -2.71.


Psomagen Beneish M-Score Historical Data

The historical data trend for Psomagen's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psomagen Beneish M-Score Chart

Psomagen Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - - -2.50 -2.50 -3.32

Psomagen Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.71 -3.26 -2.95 -3.32 -3.70

Competitive Comparison of Psomagen's Beneish M-Score

For the Diagnostics & Research subindustry, Psomagen's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psomagen's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Psomagen's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Psomagen's Beneish M-Score falls into.



Psomagen Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Psomagen for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1136+0.528 * 1.3588+0.404 * 0.9333+0.892 * 0.7871+0.115 * 1.0188
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 4.1687+4.679 * -0.154933-0.327 * 1.0942
=-3.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ₩6,402 Mil.
Revenue was 9360.202 + 8320.516 + 7636.658 + 7803.535 = ₩33,121 Mil.
Gross Profit was 1576.366 + 1811.129 + 1612.987 + 1915.883 = ₩6,916 Mil.
Total Current Assets was ₩22,731 Mil.
Total Assets was ₩44,124 Mil.
Property, Plant and Equipment(Net PPE) was ₩11,535 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩4,216 Mil.
Selling, General, & Admin. Expense(SGA) was ₩4,128 Mil.
Total Current Liabilities was ₩8,889 Mil.
Long-Term Debt & Capital Lease Obligation was ₩3,304 Mil.
Net Income was -1723.75 + -1673.628 + -1344.444 + -1270.047 = ₩-6,012 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₩0 Mil.
Cash Flow from Operations was -108.606 + 662.617 + -350.624 + 620.957 = ₩824 Mil.
Total Receivables was ₩7,304 Mil.
Revenue was 8320.342 + 11264.442 + 12405.836 + 10089.228 = ₩42,080 Mil.
Gross Profit was 2075.582 + 3396.042 + 3592.544 + 2876.291 = ₩11,940 Mil.
Total Current Assets was ₩27,027 Mil.
Total Assets was ₩49,043 Mil.
Property, Plant and Equipment(Net PPE) was ₩10,278 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩3,853 Mil.
Selling, General, & Admin. Expense(SGA) was ₩1,258 Mil.
Total Current Liabilities was ₩8,727 Mil.
Long-Term Debt & Capital Lease Obligation was ₩3,660 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(6401.956 / 33120.911) / (7303.932 / 42079.848)
=0.19329 / 0.173573
=1.1136

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(11940.459 / 42079.848) / (6916.365 / 33120.911)
=0.283757 / 0.208822
=1.3588

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (22731.161 + 11535.28) / 44123.588) / (1 - (27026.76 + 10277.744) / 49043.347)
=0.223399 / 0.239356
=0.9333

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=33120.911 / 42079.848
=0.7871

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(3853.113 / (3853.113 + 10277.744)) / (4215.588 / (4215.588 + 11535.28))
=0.272674 / 0.267642
=1.0188

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(4128.346 / 33120.911) / (1258.17 / 42079.848)
=0.124645 / 0.0299
=4.1687

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3304.398 + 8889.223) / 44123.588) / ((3659.588 + 8726.508) / 49043.347)
=0.276352 / 0.252554
=1.0942

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-6011.869 - 0 - 824.344) / 44123.588
=-0.154933

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Psomagen has a M-score of -3.70 suggests that the company is unlikely to be a manipulator.


Psomagen Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Psomagen's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Psomagen (XKRX:950200) Business Description

Traded in Other Exchanges
N/A
Address
1330 Piccard Drive, Suite 103, Rockville, MD, USA, 20850
Psomagen Inc, formerly Macrogen Corp provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-end sequencing services. The company also offers services such as personal DNA tests, clinical sequencing, research sequencing, and others.

Psomagen (XKRX:950200) Headlines

No Headlines